Literature DB >> 2893710

Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.

J A Thompson1, A M Malkinson, M D Wand, S L Mastovich, E W Mead, K M Schullek, W G Laudenschlager.   

Abstract

Metabolism of the antioxidant butylated hydroxytoluene (BHT; 2,6-di-tert-butyl-4-methylphenol) has been studied with liver and lung microsomes from rats and mice. The structures of several previously reported metabolites were confirmed, the identities of four new metabolites were determined, pathways of oxidation were investigated, and quantitative data were obtained for several of the products. Two main metabolic processes occur, hydroxylation of alkyl substituents and oxidation of the aromatic pi electron system. The former leads to the 4-hydroxymethyl product (BHT-BzOH) and a primary alcohol resulting from hydroxylation of a t-butyl group (BHT-tBuOH). Additional metabolites were produced by oxidation of BHT-BzOH to the corresponding benzaldehyde and benzoic acid derivatives. Hydroxylation of BHT-tBuOH occurs at the benzylic methyl position, and the resulting diol is oxidized further to the hydroxybenzaldehyde derivative. Oxidation of the pi system leads to the quinol, 2,6-di-t-butyl-4-hydroxy-4-methyl-2,5-cyclohexadienone, the quinone, 2,6-di-t-butyl-4-benzoquinone, and the quinone methide, 2,6-di-t-butyl-4-methylene-2,5-cyclohexadienone. Derivatives of the quinol and quinone with a hydroxylated t-butyl group were also formed. Quantitative data demonstrate that BHT-BzOH is the principal metabolite in rat liver and lung microsomes. On the other hand, mice produce large amounts of both BHT-BzOH and BHT-tBuOH in these tissues. The metabolite profile was similar in rat liver and lung. Mouse lung, however, produced more quinone relative to other metabolites than mouse liver.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2893710

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

1.  The naphthol selective estrogen receptor modulator (SERM), LY2066948, is oxidized to an o-quinone analogous to the naphthol equine estrogen, equilenin.

Authors:  Teshome B Gherezghiher; Bradley Michalsen; R Esala P Chandrasena; Zhihui Qin; Johann Sohn; Gregory R J Thatcher; Judy L Bolton
Journal:  Chem Biol Interact       Date:  2012-01-28       Impact factor: 5.192

2.  Selective estrogen receptor modulator (SERM) lasofoxifene forms reactive quinones similar to estradiol.

Authors:  Bradley T Michalsen; Teshome B Gherezghiher; Jaewoo Choi; R Esala P Chandrasena; Zhihui Qin; Gregory R J Thatcher; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2012-06-14       Impact factor: 3.739

3.  Analysis of protein covalent modification by xenobiotics using a covert oxidatively activated tag: raloxifene proof-of-principle study.

Authors:  Ju Liu; Qian Li; Xiaofeng Yang; Richard B van Breemen; Judy L Bolton; Gregory R J Thatcher
Journal:  Chem Res Toxicol       Date:  2005-09       Impact factor: 3.739

4.  Uterine peroxidase-catalyzed formation of diquinone methides from the selective estrogen receptor modulators raloxifene and desmethylated arzoxifene.

Authors:  Hong Liu; Zhihui Qin; Gregory R J Thatcher; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2007-07-13       Impact factor: 3.739

5.  Metabolism of 3,5-di-t-butyl-4-methylphenyl N-methylcarbamate, Terbucarb, on isolated rat hepatocytes.

Authors:  T Suzuki; K Yaguchi; Y Nakagawa; T Suga
Journal:  Bull Environ Contam Toxicol       Date:  1995-05       Impact factor: 2.151

6.  Foxm1 transcription factor is required for macrophage migration during lung inflammation and tumor formation.

Authors:  D Balli; X Ren; F-S Chou; E Cross; Y Zhang; V V Kalinichenko; T V Kalin
Journal:  Oncogene       Date:  2011-12-05       Impact factor: 9.867

7.  Deciphering Key Interactions of Ligands with CYP3A4-Template* system.

Authors:  Yasushi Yamazoe; Takashi Yamada; Akihiko Hirose; Norie Murayama
Journal:  Food Saf (Tokyo)       Date:  2021-02-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.